Pleural malignancies

Seminars in Radiation Oncology

Volumn 20, Issue 3, 2010, Pages 208-214

  Friedberg, Joseph S ^a   Cengel, Keith A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMIFOSTINE; BETA INTERFERON; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; INTERLEUKIN 2; MITOMYCIN C; PACLITAXEL; PEMETREXED; PHOTOSENSITIZING AGENT; SODIUM THIOSULFATE;

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CATHETER; CLINICAL TRIAL; GENE THERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; NEPHROTOXICITY; PALLIATIVE THERAPY; PHOTODYNAMIC THERAPY; PLEURA BIOPSY; PLEURA CANCER; PLEURA MESOTHELIOMA; PLEURA METASTASIS; PLEURODESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; PROTON RADIATION; REVIEW; SINGLE DRUG DOSE; THORACOCENTESIS; X RAY;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; PALLIATIVE CARE; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; PLEURODESIS; RADIOTHERAPY, CONFORMAL;

EID: 77954836197     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2010.01.009     Document Type: Review

References (27)

1. Vallieres E., Shepherd F.A., Crowley J., et al. The IASLC lung cancer staging project: Proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:1049-1059.
2. Wagenfeld L., Zeitz O., Richard G. Visual loss after povidone-iodine pleurodesis. N Engl J Med 2007, 357:1264-1265.
3. Dresler C.M., Olak J., Herndon J.E., et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005, 127:909-915.
4. Kuzniar T.J., Blum M.G., Kasibowska-Kuzniar K., et al. Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis. Ann Thorac Surg 2006, 82:1976-1981.
5. Warren W.H., Kalimi R., Khodadadian L.M., et al. Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg 2008, 85:1049-1055.
6. Krug L.M., Pass H.I., Rusch V.W., et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009, 27:3007-3013.
7. Tilleman T.R., Richards W.G., Zellos L., et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study. J Thorac Cardiovasc Surg 2009, 138:405-411.
8. Zellos L., Richards W.G., Capalbo L., et al. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2009, 137:453-458.
9. Forster K.M., Smythe W.R., Starkschall G., et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: Clinical implementation. Int J Radiat Oncol Biol Phys 2003, 55:606-616.
10. Aokage K, Yoshida J, Ishii G, et al: The impact on survival of positive intraoperative pleural lavage cytology in patients with non-small-cell lung cancer. J Thorac Cardiovasc Surg 2009 (in press).
11. Vogelzang N.J., Rusthoven J.J., Symanowski J., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003, 21:2636-2644.
12. Cohen M.H., Gootenberg J., Keegan P., et al. FDA drug approval summary: Bevacizumab (Avastin) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer. Oncologist 2007, 12:713-718.
13. Rusch V., Saltz L., Venkatraman E., et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 1994, 12:1156-1163.
14. Yellin A., Simansky D.A., Paley M., et al. Hyperthermic pleural perfusion with cisplatin: Early clinical experience. Cancer 92 2001, 2197:2197-2203.
15. McAleer M.F., Tsao A.S., Liao Z. Radiotherapy in malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2009, 75:326-337.
16. Yajnik S., Rosenzweig K.E., Mychalczak B., et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2003, 56:1319-1326.
17. Allen A.M., Czerminska M., Janne P.A., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006, 65:640-645.
18. Lee C., Bayman N., Swindell R., et al. Prophylactic radiotherapy to intervention sites in mesothelioma: A systematic review and survey of UK practice. Lung Cancer 2009, 66:150-156.
19. Friedberg J.S. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 2009, 21:177-187.
20. Cengel K.A., Hahn S.M. Photodynamic therapy. Cancer: Principles and Practice of Oncology 2008, 767-774. Lippincott Williams and Wilkins, Philadelphia, PA. (ed 8). V. DeVita, T. Lawrence, S. Tosenberg (Eds.).
21. Pass H.I., Temeck B.K., Kranda K., et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997, 4:628-633.
22. Friedberg J.S., Mick R., Stevenson J., et al. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg 2003, 75:952-959.
23. Schouwink H., Ruevekamp M., Oppelaar H., et al. Photodynamic therapy for malignant mesothelioma: Preclinical studies for optimization of treatment protocols. Photochem Photobiol 2001, 73:410-417.
24. Friedberg J.S., Mick R., Stevenson J.P., et al. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol 2004, 22:2192-2201.
25. Pass H.I., Donington J.S. Use of photodynamic therapy for the management of pleural malignancies. Semin Surg Oncol 1995, 11:360-367.
26. Sterman D.H., Recio A., Carroll R.G., et al. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: High rate of antitumor immune responses. Clin Cancer Res 2007, 13:4456-4466.
27. Lucchi M., Chella A., Melfi F., et al. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur J Cardiothorac Surg 2007, 31:529-533.